Rx Relief Named to Sia List - Aug 18

Share this article
Spread the word on social media
The Story
Rx relief, a Joint Commission Certified pharmacy staffing firm and division of PrideStaff, was named to Staffing Industry Analysts' 2026 list of the Largest Allied Healthcare Staffing Firms, the company announced Aug. 18. The recognition signals third-party validation for Rx relief's placement in the allied healthcare staffing market.
Why It Matters For Your Portfolio
- Third-party recognition can support demand and pricing power, which matters if you model revenue and margins for staffing peers; investors should note the company callout in SIA's 2026 list.
- Multiple data points are available for valuation analysis: 58%, $61.7, $25 and $2.3, and these figures can be used to stress-test growth, revenue and per-share scenarios.
- If 58% is treated as a growth indicator, it could materially change forward projections and comparables screening, pressuring or boosting multiples relative to public staffing peers.
- The $61.7, $25 and $2.3 figures offer anchors for scenario work, helping you derive implied price/earnings or enterprise value metrics when comparing to listed staffing and healthcare service companies.
The Trade
Analysts and investors focused on healthcare staffing and valuation models should care, especially those conducting comparables or precedent transaction analysis. Watch for PrideStaff or SIA follow-ups and any public filings or detailed metrics that break down the $61.7, $25 and $2.3 figures so you can refine multiples and sensitivity tables. How you adjust your model will depend on which of those data points you treat as revenue, margin or per-share metrics.